EMMA Emmaus Life Sciences Inc.

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$1.45    OTCQX
As of 01/21/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  05/09/2000
Outstanding shares:  49,311,864
Average volume:  12,334
Market cap:   $73,967,796
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -7.87
PB ratio:   -1.43
PS ratio:   3.10
Return on equity:   63.61%
Net income %:   -40.29%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy